CLINICAL STUDIES
Gene transfer of nitric oxide synthase
Effects on endothelial biology
Josef Niebauer, MD* ,1,
J.ózef Dulak, PhD*,2,
Jason R. Chan, BS*,
Philip S. Tsao, PhD*,3 and
John P. Cooke, MD, PhD, FACC*,4
* Section of Vascular Medicine, Division of Cardiovascular Medicine, Stanford University, Stanford, California, USA
Herzzentrum der Universität Leipzig, Kardiologie, Leipzig, Germany
Manuscript received September 24, 1998;
revised manuscript received May 17, 1999,
accepted June 10, 1999.
Reprint requests and correspondence: Dr. John P. Cooke, Director, Vascular Medicine, Falk Cardiovascular Research Center, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, California 94305-5246 John.Cooke{at}stanford.edu
OBJECTIVES
The purpose of the study was to investigate the role of nitric oxide (NO) in monocyte-endothelial interaction by augmenting NO release via transfection of human endothelial cells (ECs) with EC NO synthase (eNOS) DNA.
BACKGROUND
Enhancement of NO synthesis by L-arginine or shear stress reduces endothelial adhesiveness for monocytes and inhibits atherogenesis. To elucidate further the underlying mechanism, we augmented NO synthase expression by transfection of human EC.
METHODS
Liposome-mediated transfection of EC was performed with a plasmid construct containing the gene encoding eNOS. Expression of eNOS was confirmed by reverse transcriptionpolymerase chain reaction (RT-PCR). Endothelial cells were exposed to human monocytoid cells, and adherent cells were quantitated using a computer-assisted program. Nitric oxide was measured by chemiluminescence.
RESULTS
The NO levels were not different in EC that were either not transfected, transfected with beta-gal or liposomes only. The nitric oxide synthase (NOS) transfection increased NO release by +60% (n = 6), which increased further when EC were stimulated by shear stress (24 h) by +137% (n = 5) as compared with untransfected, unstimulated EC (both p < 0.05). The RT-PCR revealed diminished monocyte chemotactic protein-1 (MCP-1) expression in eNOS transfected EC. There was an inverse relation between NO levels and monocyte binding (r = 0.5669, p < 0.002). Stimulation of EC with tumor necrosis factor-alpha (TNF-alpha; 250 U/ml) led to a decrease in NO synthesis, and an increase in monocyte binding. Cells transfected with NOS were resistant to both effects of TNF-alpha.
CONCLUSIONS
Endothelial cells transfected with eNOS synthesize an increased amount of NO; this is associated with diminished MCP-1 expression and monocyte-endothelial binding. The reduction in monocyte-endothelial binding persists even after cytokine stimulation.
|
Abbreviations and Acronyms
| | ANOVA | = analysis of variance | | EC | = endothelial cells | | eNOS | = endothelial cell nitric oxide synthase | | MCP-1 | = monocyte chemotactic protein-1 | NF B | = nuclear factor B | | NO | = nitric oxide | | NOS | = nitric oxide synthase | | RT-PCR | = reverse transcriptionpolymerase chain reaction | TNF- | = tumor necrosis factor-alpha | | VCAM | = vascular cell adhesion molecule |
|
This article has been cited by other articles:

|
 |

|
 |
 
S. Sixt, A. Rastan, S. Desch, M. Sonnabend, A. Schmidt, G. Schuler, and J. Niebauer
Exercise training but not rosiglitazone improves endothelial function in prediabetic patients with coronary disease
European Journal of Cardiovascular Prevention & Rehabilitation,
August 1, 2008;
15(4):
473 - 478.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Peschel, S. Sixt, F. Beitz, M. Sonnabend, G. Muth, H. Thiele, A. Tarnok, G. Schuler, and J. Niebauer
High, but not moderate frequency and duration of exercise training induces downregulation of the expression of inflammatory and atherogenic adhesion molecules
European Journal of Cardiovascular Prevention & Rehabilitation,
June 1, 2007;
14(3):
476 - 482.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Niebauer, A. L. Clark, K. M. Webb-Peploe, R. Boger, and A. J.S. Coats
Home-based exercise training modulates pro-oxidant substrates in patients with chronic heart failure
Eur J Heart Fail,
March 2, 2005;
7(2):
183 - 188.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Niebauer, A. J. Maxwell, P. S. Lin, D. Wang, P. S. Tsao, and J. P. Cooke
NOS inhibition accelerates atherogenesis: reversal by exercise
Am J Physiol Heart Circ Physiol,
July 11, 2003;
285(2):
H535 - H540.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. van Haperen, M. de Waard, E. van Deel, B. Mees, M. Kutryk, T. van Aken, J. Hamming, F. Grosveld, D. J. Duncker, and R. de Crom
Reduction of Blood Pressure, Plasma Cholesterol, and Atherosclerosis by Elevated Endothelial Nitric Oxide
J. Biol. Chem.,
December 6, 2002;
277(50):
48803 - 48807.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Niebauer, P. S Tsao, P. S Lin, R. E Pratt, and J. P Cooke
Cholesterol-induced upregulation of angiotensin II and its effects on monocyte-endothelial interaction and superoxide production
Vascular Medicine,
August 1, 2001;
6(3):
133 - 138.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. T. KOVALA, K. A. HARVEY, P. McGLYNN, G. BOGUSLAWSKI, J. G. N. GARCIA, and D. ENGLISH
High-efficiency transient transfection of endothelial cells for functional analysis
FASEB J,
December 1, 2000;
14(15):
2486 - 2494.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. M. Channon, H. Qian, and S. E. George
Nitric Oxide Synthase in Atherosclerosis and Vascular Injury : Insights From Experimental Gene Therapy
Arterioscler Thromb Vasc Biol,
August 1, 2000;
20(8):
1873 - 1881.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|